Raxibacumab regulatory update

FDA's Anti-Infective Drugs Advisory Committee will meet on Nov. 2 to discuss a BLA from GlaxoSmithKline's Human Genome Sciences Inc. subsidiary for raxibacumab to treat inhalational anthrax. The huma...